- Zacks•2 hours agoThe Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan, AstraZeneca and Johnson & Johnson
The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan, AstraZeneca and Johnson & Johnson
- Reuters•10 hours ago
Kraft Heinz's dropped bid to buy Unilever is the third-largest M&A deal to collapse, according to Thomson Reuters data, adding to a recent run of failures that highlights the appetite for the pursuit of audacious mega-mergers. The abrupt U-turn by U.S. foods giant Kraft at the weekend pushed the value of deals withdrawn this year to $205.2 billion, compared with $53.6 billion at the same point in 2016.
- Financial Times•12 hours ago
Big pharma thinks it has spotted its next big opportunity - an untreatable silent killer that affects millions of people. In recent months, large drugmakers including Allergan, Gilead and Novartis have ...
AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance
Allergan plc (AGN)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||246.82 - 249.75|
|52 Week Range||184.50 - 301.32|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||6.49|
|Dividend & Yield||2.80 (1.13%)|
|1y Target Est||N/A|